文献速递其他结缔组织病类风湿关节炎系统性红斑狼疮

自身免疫性风湿病患者长新冠风险更高:美国国家数据回顾性队列分析

Higher risk of Long COVID among patients with autoimmune rheumatic diseases and immunomodulatory therapy: a retrospective cohort analysis of national US data.
PubMed 文献 · Arthritis Rheumatol · 2026-10-14

匹配队列187,106例中,AIRD患者长新冠发生率为2.8%,非AIRD为1.5%;AIRD与长新冠风险升高相关(aHR 1.56,95%CI 1.45-1.67)。

要点

  • AIRD患者长新冠风险较非AIRD患者升高(aHR 1.56,95%CI 1.45-1.67)。
  • 利妥昔单抗或糖皮质激素暴露与AIRD患者长新冠风险升高相关。
  • 干燥综合征与AIRD患者长新冠风险升高相关。

核心结论

  • AIRD患者发生长新冠的风险高于非AIRD患者,需识别该人群长新冠潜在危险因素以减轻长期影响。

研究设计与样本

  • 采用1:1最近邻倾向评分匹配,按年龄匹配并精确匹配性别、种族/民族、SARS-CoV-2变异优势流行期和数据贡献机构,比较AIRD患者与匹配非AIRD对照。
  • 使用多变量Cox回归模型估计风险比;在AIRD患者中评估AIRD类型和急性COVID-19前药物暴露与长新冠风险的关系。

主要发现

  • 匹配队列共187,106例患者,AIRD患者长新冠发生率为2.8%,非AIRD患者为1.5%。
  • 多变量分析中,AIRD与非AIRD患者相比长新冠风险升高(aHR 1.56,95%CI 1.45-1.67)。
  • AIRD患者中,急性COVID-19严重程度较高、肺部疾病、肥胖以及利妥昔单抗或糖皮质激素暴露与长新冠风险升高相关。
  • 干燥综合征与AIRD患者长新冠风险升高相关。

关键数值与推荐

  • 长新冠定义为首次感染后28至365天出现ICD-10-CM编码U09.9或长新冠门诊就诊。

临床怎么用

  • 对AIRD患者应关注长新冠风险,尤其是急性COVID-19严重程度较高、合并肺部疾病或肥胖、以及使用利妥昔单抗或糖皮质激素者。
  • 干燥综合征患者可能需加强长新冠监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about the prevalence of and factors associated with Long COVID in patients with autoimmune rheumatic diseases (AIRDs). METHODS: We conducted a retrospective cohort study using data from the National Clinical Cohort Collaborative (N3C). We included adults with a first documented SARS-CoV-2 infection between September 2021 and December 2023, with follow-up through December 2024. Long COVID was defined as ICD-10-CM code U09.9 or a Long COVID clinic visit occurring 28 to 365 days after first infection. We compared patients with AIRD with matched non-AIRD controls using 1:1 nearest-neighbor propensity score matching on age with exact matching on sex, race/ethnicity, SARS-CoV-2 variant-dominant period, and data-contributing organization. We estimated hazard ratios using multivariable Cox regression models. Among people with AIRD, we assessed risk by AIRD type and medication exposure before acute COVID-19. RESULTS: In the matched cohort of 187,106 patients, Long COVID occurred in 2.8% of AIRD patients and 1.5% among non-AIRD patients. In multivariable analyses, AIRD was associated with an increased risk of Long COVID compared with non-AIRD patients (aHR 1.56, 95% CI 1.45-1.67). Among patients with AIRD, higher acute COVID-19 severity, pulmonary disease, obesity, and exposure to rituximab or glucocorticoids were associated with an increased risk of Long COVID. Sjögren's syndrome was associated with a higher risk of Long COVID. CONCLUSION: The higher risk of developing Long COVID among AIRD patients compared with those without AIRD underscores the need to identify potential risk factors for Long COVID in this population to minimize its long-term effects.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Singh N, Anzalone AJ, Stevenson H, et al. Higher risk of Long COVID among patients with autoimmune rheumatic diseases and immunomodulatory therapy: a retrospective cohort analysis of national US data. Arthritis Rheumatol. 2026. PMID: 42870675. doi:10.1002/art.70361

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。